The hepatitis B virus X protein downregulates NF-κB signaling pathways through decreasing the Notch signaling pathway in HBx-transformed L02 cells

International Journal of Oncology

Volumn 42, Issue 5, 2013, Pages 1636-1643

  Luo, Jing ^a   Zhou, Haiyan ^a   Wang, Fan ^a   Xia, Xiumei ^a   Sun, Qian ^a   Wang, Ronghua ^a   Cheng, Bin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Crosstalk; Hepatitis B virus X protein; Hepatocellular carcinoma; NF B; Notch

Indexed keywords

HEPATITIS B VIRUS X PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JAGGED1; NOTCH RECEPTOR; NOTCH1 RECEPTOR; PROTEIN P50; SMALL INTERFERING RNA; SYNAPTOTAGMIN I;

ARTICLE; CYTOPLASM; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

CARCINOMA, HEPATOCELLULAR; CELL LINE; DIPEPTIDES; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; NF-KAPPA B; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 84876008146     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1842     Document Type: Article

References (34)

1. Jemal A, Bray F, Melissa M, et al: Global Cancer Statistics.CA Cancer J Clin 55: 74-108, 2005.
2. Hashem BE and Rudolph KL: Hepatocellular carcinoma epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576, 2007. (Pubitemid 46890874)
3. Feitelson MA and Duan LX: Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am J Pathol 150: 1141-1157, 1997. (Pubitemid 27152632)
4. Wang F, Zhou H, Xia X, et al: Activated Notch signaling is required for hepatitis B virus X protein to promote proliferation and survival of human hepatic cells. Cancer Lett 298: 64-73, 2010.
5. Lai EC: Notch signaling: control of cell communication and cell fate. Development 131: 965-973, 2004. (Pubitemid 38380451)
6. Miele L: Notch signaling. Clin Cancer Res 12: 1074-1079, 2006. (Pubitemid 43342494)
7. Miele L, Golde T and Osborne B: Notch signaling in cancer. Curr Mol Med 6: 905-918, 2006. (Pubitemid 44883940)
8. Kopan R and Ilagan MX: Gamma-secretase: proteasome of the membrane? Nat Rev Mol Cell Biol 5: 499-504, 2004.
9. Berman JN and Look AT: Targeting transcription factors in acute leukemia in children. Curr Drug Targets 8: 727-737, 2007. (Pubitemid 47603402)
10. Rangarajan A, Talora C, Okuyama R, et al: Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J 20: 3427-3436, 2001. (Pubitemid 32634350)
11. Ronchini C and Capobianco AJ: Induction of cyclin D1 transcription and CDK2 activity by Notch(ic): implication for cell cycle disruption in transformation by Notch(ic). Mol Cell Biol 1: 5925-5934, 2001. (Pubitemid 32737809)
12. Baonza A and Freeman M: Control of cell proliferation in the Drosophila eye by Notch signaling. Dev Cell 8: 529-539, 2005. (Pubitemid 40450742)
13. Cheng P, Zlobin A, Volgina V, et al: Notch-1 regulates NF-kappaB activity in hemopoietic progenitor cells. J Immunol 167: 4458-4467, 2001. (Pubitemid 32954323)
14. Klinakis A, Szabolcs M, Politi K, et al: Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice. Proc Natl Acad Sci USA 103: 9262-9267, 2006. (Pubitemid 43902566)
15. Diao J, Garces R and Richardson CD: X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis. Cytokine Growth Factor Rev 12: 189-205, 2001. (Pubitemid 32588145)
16. Seto E, Mitchell PJ and Yen TS: Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature 344: 72-74, 1990.
17. Lucito R and Schneider RJ: Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C. J Virol 66: 983-991, 1992.
18. Meyer M, Caselmann WH, Schluter V, et al: Hepatitis B virus transactivator MHBst: activation of NF-kappa B, selective inhibition by antioxidants and integral membrane localization. EMBO J 11: 2991-3001, 1992.
19. Campbell KJ and Perkins ND: Regulation of NF-kappaB function. Biochem Soc Symp 73: 165-180, 2006.
20. Perkins ND: Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8: 49-62, 2007. (Pubitemid 46012014)
21. Maniati E, Bossard M, Cook N, et al: Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits PPARγ expression and promotes pancreatic cancer progression in mice. J Clin Invest 121: 4685-4699, 2011.
22. Pan H, Zhou W, He W, et al: Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-κB activity via the Notch-1 pathway. Int J Mol Med 30: 337-343, 2012.
23. Schwarzer R, Dörken B and Jundt F: Notch is an essential upstream regulator of NF-κB and is relevant for survival of Hodgkin and Reed-Sternberg cells. Leukemia 26: 806-813, 2012.
24. Cheng B, Zheng Y, Guo XR, et al: Hepatitis B viral X protein alters the biological features and expressions of DNA repair enzymes in LO2 cells. Liver Int 30: 319-326, 2010.
25. Wang Z, Banerjee S, Ahmad A, et al: Activated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of Notch and NF-κB signaling pathways. PLoS One 6: e20537, 2011.
26. Berasain C, Castillo J, Perugorria MJ, et al: Infammation and liver cancer: new molecular links. Ann NY Acad Sci 1155: 206-221, 2009.
27. Lupberger J and Hildt E: Hepatitis B virus-induced concogenesis. World J Gastroenterol 13: 74-81, 2007.
28. Qiao L, Zhang H, Yu J, et al: Constitutive activation of NF-kappaB in human hepatocellular carcinoma: evidence of a cytoprotective role. Hum Gene Ther 17: 280-290, 2006.
29. Gao J, Chen C, Hong L, et al: Expression of Jagged1 and its association with hepatitis B virus X protein in hepatocellular carcinoma. Biochem Biophys Res Commun 356: 341-347, 2007. (Pubitemid 46452552)
30. Karin M: NF-kappaB and cancer: mechanisms and targets. Mol Carcinog 45: 355-361, 2006.
31. Luedde T and Schwabe RF: NF-κB in the liver - linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 8: 108-118, 2011.
32. Beg AA and Baldwin JR: The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. Genes Dev 7: 2064-2070, 1993.
33. Oakley F, Mann J, Ruddell RG, et al: Basal expression of IkappaBalpha is controlled by the mammalian transcriptional repressor RBP-J (CBF1) and its activator Notch1. J Biol Chem 278: 24359-24370, 2003. (Pubitemid 37548587)
34. Monsalve E, Ruiz-García A, Baladrón V, et al: Notch1 upregulates LPS-induced macrophage activation by increasing NF-kappaB activity. Eur J Immunol 39: 2556-2570, 2009.